Strata Critical Medical, Inc.

For the period ended Dec 31, 2025. Filed Mar 3, 2026.

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2025 · Filed Mar 3, 2026

SRTA$6.05+8.8%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Consolidated Statements of Operations F-

(in thousands, except share and per share data)

	Year Ended December 31,
	2025	2024
Revenue	$197,141	$146,817
Cost of revenue	156,015	117,228
Gross profit	41,126	29,589
Operating expenses
Selling, general and administrative	60,875	50,856
Amortization of intangible assets	2,604	1,258
Total operating expenses	63,479	52,114
Operating loss from continuing operations	(22,353)	(22,525)
Other non-operating income (loss)
Interest income	4,241	7,214
Change in fair value of warrant liabilities	4,278	(850)
Change in fair value of assets and other liabilities	(1,037)	—
Realized loss from sales of short-term investments	(5,195)	—
Total other non-operating income	2,287	6,364
Loss from continuing operations before income taxes	(20,066)	(16,161)
Income tax expense from continuing operations	—	—
Net loss from continuing operations	(20,066)	(16,161)
Net income (loss) from discontinued operations	61,413	(11,146)
Net income (loss)	$41,347	$(27,307)
Basic and diluted earnings (loss) per share
Continuing operations	$(0.24)	$(0.21)
Discontinued operations	$0.75	$(0.14)
Total basic and diluted earnings (loss) per share	$0.50	$(0.35)
Weighted-average number of shares outstanding:
Basic	82,092,345	77,499,423
Diluted	82,092,345	77,499,423

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.